Alejandra Carvajal, SVP, Chief Legal Officer at Mersana Therapeutics, Inc. (MRSN), sold 4,381 shares at $2.71 ($12K) on 2024-01-16, disclosed to the SEC on 2024-01-17.
Scheduled sale ($12k) by SVP, Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MRSN | SELL | 2025-01-15 | $2K | — | Filing → |
| MRSN | SELL | 2024-10-07 | $27K | — | Filing → |
| MRSN | SELL | 2023-04-28 | $15K | — | Filing → |